←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Trials, Dose Escalation Design
Scott M. Berry
PhD
🏢Berry Consultants🌐USA
President and Senior Statistical Scientist
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Scott Berry leads Berry Consultants and has been central to the implementation of Bayesian adaptive and platform trial designs across oncology. His work has supported trials including I-SPY and GBM AGILE that use adaptive dose and arm selection. He is widely recognized as an innovator in adaptive trial methodology.
Share:
🧪Research Fields 研究领域
Bayesian adaptive design
platform trials
dose finding
biostatistics
oncology methodology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Scott M. Berry 的研究动态
Follow Scott M. Berry's research updates
留下邮箱，当我们发布与 Scott M. Berry（Berry Consultants）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment